GLP-1 RA use was associated with significantly lower risk of certain cancers compared with metformin use and insulin use.
The bills, which have advanced in the Senate, would require schools to take certain preventative measures to protect student ...
Jaeb Center for Health Research conducted a randomized controlled trial evaluating the impact of automated insulin delivery ...
The following is a summary of “Hematologic Cancers Among Patients With Type 2 Diabetes Prescribed GLP-1 Receptor Agonists,” ...
Despite weight loss and glycemic control, experts caution that type 2 diabetes remission is not a cure and that pancreatic ...
GLP-1 RA use is associated with better graft and patient survival among kidney transplant recipients with diabetes.
13d
News-Medical.Net on MSNGLP-1 drugs may cut risk of leukemia and lymphoma in type 2 diabetes patientsResearchers found that GLP-1 receptor agonists (GLP-1RAs) significantly reduce the risk of several blood cancers in type 2 ...
2d
News-Medical.Net on MSNExploring the therapeutic potential of flavonoids in type 2 diabetesType 2 diabetes mellitus (T2DM) is a chronic metabolic disorder with a rapidly increasing global prevalence. It is primarily ...
For kidney transplant recipients with type 2 diabetes, use of glucagon-like peptide-1 receptor agonists was associated with ...
We recently published a list of 10 Best Diabetes Stocks To Buy According to Billionaires. In this article, we are going to ...
People without diabetes can lose up to 13% of their starting weight in 6 months using tirzepatide (Mounjaro) as an off-label ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results